Key result
The presence of A/G renin genetic polymorphism was not significantly different between heart failure patients (60.46%) and healthy controls (37.5%) (p=0.106).
Why the study?
Is A/G renin genetic polymorphism associated with the pathogenesis of heart failure?
Case-Control (n=83)
No
Is A/G renin genetic polymorphism associated with the pathogenesis of heart failure?
Absolute Event Rate: 60.46% vs 37.5%
p-value: p=0.106
This study found no significant association between A/G renin genetic polymorphisms and the pathogenesis of heart failure.
No association seen in this case-control study; leaves open any role of renin polymorphism in heart failure pathogenesis and requires larger confirmation.
BACKGROUND: Genetic polymorphism of renin-angiotensin-aldosterone system affects the pathogenesis of hypertension (HTN), ischemic heart disease (IHD) and heart failure (HF). The purpose of our study is to analyze A/G renin genetic polymorphism in heart failure patients. METHODS: We investigated renin polymorphism in 83 subjects hospitalized in the Cardiology Department of the Rehabilitation Hospital Cluj-Napoca, using the PCR amplification method. 43 patients were diagnosed with heart failure [NYHA III-IV class], and 40 subjects without cardiovascular disease (control group). The NT-proBNP and the presence of cardiovascular risk factors were assessed. RESULTS: Heart failure etiology was IHD in 60.46% of patients. The average value of NT-pro BNP was 2991.24 ± 2034.6 pg/ml. As it was expected, HF patients presented low lipid levels: total cholesterol = 162.36 ± 38.28 mg/dl, LDL-Cholesterol = 104.88 ± 27.60 mg/dl, triglycerides= 109.12 ± 55.84 mg/dl, HDL-Co = 35.68 ± 9.55 mg/dl. A/G renin genetic polymorphism [with pathogenic potential] in heart failure patients was of 60.46% (homozygote 4.65% and heterozygote 55.81%). Conversely, pathogenic mutations were found only in 38.46% of hypertensive patients, but also in 55.88% and 22.22% patients with obesity/overweight and diabetes. The heterozygote form was found in only 37.5% of control subjects. CONCLUSION: This study showed no involvement of A/G renin polymorphisms in the pathogenesis of HF.
No takes yet. Share an insight, caveat, or question.
Pop et al. (2015) conducted a case-control in Heart failure (n=83). A/G renin genetic polymorphism vs. Control subjects without cardiovascular disease was evaluated on Frequency of A/G renin genetic polymorphism (p=0.106). The presence of A/G renin genetic polymorphism was not significantly different between heart failure patients (60.46%) and healthy controls (37.5%) (p=0.106).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: